Bevacizumab Concentrate For Injection About
Discover the trending BEVATAS 400 Bevacizumab Concentrate For Injection-a masterful, gilt-edged solution in advanced cancer therapy. This single-use, prescription-only vial delivers a towering standard in anti-cancer treatment, containing 400 mg/16 mL Bevacizumab for intravenous administration by healthcare professionals. Trusted as a top-tier, colorless to pale yellow liquid, BEVATAS 400 is designed for efficacy in multiple cancers, including colorectal, lung, glioblastoma, renal cell, and cervical. Last chance for effective therapy-be sure of authentic supply from leading exporters, suppliers, and traders in India.
Key Advantages and Versatile Applications of BEVATAS 400
BEVATAS 400 offers a gilt-edged advantage in targeting cancers such as colorectal, lung, glioblastoma, renal cell, and cervical. This monoclonal antibody is highly valued in oncology centers, hospitals, and specialized clinics, making it essential for both general and highly specific cancer therapies. Administered strictly by medical professionals as an intravenous infusion, BEVATAS 400 ensures effective treatment in advanced cancer management with its sterile, single-use, preservative-free formulation.
Export Market Reach and Reliable Dispatch Solutions
BEVATAS 400 enjoys a strong presence in globally recognized export markets. Shipped goods are securely packed in temperature-controlled, protective materials to maintain efficacy, with every vial dispatched in compliance with international standards. Packing & dispatch efficiency ensures minimal delivery times, typically within a few days to a week once the order is confirmed. Suppliers and traders from India are reputed for maintaining high standards in packaging detail and swift logistics, catering to oncologists around the world.
FAQ's of Bevacizumab Concentrate For Injection:
Q: How should BEVATAS 400 Bevacizumab Concentrate For Injection be administered?
A: BEVATAS 400 must be administered intravenously as an infusion and should always be handled by trained healthcare professionals in a clinical setting.
Q: What cancers is BEVATAS 400 commonly used to treat?
A: BEVATAS 400 is indicated in the treatment of various cancers, including colorectal cancer, lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer.
Q: When should BEVATAS 400 not be used?
A: BEVATAS 400 is strictly for intravenous use and should not be self-administered. It should not be used in individuals with hypersensitivity to the active ingredient or other formulation components.
Q: Where should BEVATAS 400 be stored before use?
A: The vial should be stored in a refrigerator at a temperature between 2C and 8C. It must not be frozen and should be protected from light.
Q: What is the general process for receiving BEVATAS 400 internationally?
A: International orders are packed securely under regulated conditions, shipped efficiently from leading Indian suppliers, and delivered according to export market standards to ensure product integrity upon arrival.